Cargando…
Management of cutaneous neurofibroma: current therapy and future directions
Neurofibromatosis type 1 (NF1) is a life-long neurocutaneous disorder characterized by a predisposition to tumor development, including cutaneous neurofibroma (cNF), the hallmark of the disease. cNF is a histologically benign, multicellular tumor formed in virtually most individuals with NF1. It is...
Autores principales: | Chamseddin, Bahir H, Le, Lu Q |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317049/ https://www.ncbi.nlm.nih.gov/pubmed/32642736 http://dx.doi.org/10.1093/noajnl/vdz034 |
Ejemplares similares
-
New insights into the neurofibroma tumor cells of origin
por: Li, Stephen, et al.
Publicado: (2019) -
Current and Future Directions in MS Management: Key Considerations for Managed Care Pharmacists
por: Lipsy, Robert J., et al.
Publicado: (2009) -
Cutaneous neurofibromas in the genomics era: current understanding and open questions
por: Allaway, Robert J., et al.
Publicado: (2018) -
Current and future management approaches for rheumatoid arthritis
por: Breedveld, Ferdinand C
Publicado: (2002) -
Renin-Angiotensin Aldosterone System and Hypertension: Current Approaches and Future Directions
por: Flack, John M., et al.
Publicado: (2007)